PolyI:C-induced neurodevelopmental animal model for schizophrenia

Japanese Journal of Neuropsychopharmacology

Volumn 31, Issue 5-6, 2011, Pages 201-207

  Ibi, Daisuke ^a,b   Nagai, Taku ^a   Nabeshima, Toshitaka ^b   Yamada, Kiyofumi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MEIJO UNIVERSITY   (Japan)

Author keywords

DISC1; Gene environment interactions; Neurodevelopment; PolyI:C; Schizophrenia

Indexed keywords

DISRUPTED IN SCHIZOPHRENIA 1 PROTEIN; POLYINOSINIC POLYCYTIDYLIC ACID;

ADULTHOOD; ANIMAL MODEL; EXPERIMENTAL MODEL; GENOTYPE ENVIRONMENT INTERACTION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PHENOTYPIC VARIATION; PROGENY; REVIEW; SCHIZOPHRENIA; TRANSGENIC MOUSE;

ANIMALS; DISEASE MODELS, ANIMAL; GENE-ENVIRONMENT INTERACTION; GLUTAMIC ACID; HIPPOCAMPUS; HUMANS; LIGANDS; MICE; NERVE TISSUE PROTEINS; NEUROGENESIS; POLY I-C; SCHIZOPHRENIA; TOLL-LIKE RECEPTOR 3;

EID: 84455175946     PISSN: 13402544     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Arion, D., Unger, T., Lewis, D. A., Levitt, P. and Mirnics, K. (2007) Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol Psychiatry, 62: 711-721. (Pubitemid 47374650)
2. Brandon, N. J., Handford, E. J., Schurov, I., Rain, J. C., Pelling, M., Duran-Jimeniz, B., Camargo, L. M., Oliver, K. R., Beher, D., Shearman, M. S. and Whiting, P. J. (2004) Disrupted in Schizophrenia 1 and Nudel form a neurodevelopmentally regulated protein complex: Implications for schizophrenia and other major neurological disorders. Mol Cell Neurosci, 25: 42-55. (Pubitemid 38220863)
3. Cameron, J. S., Alexopoulou, L., Sloane, J. A., DiBernardo, A. B., Ma, Y., Kosaras, B., Flavell, R., Strittmatter, S. M., Volpe, J., Sidman, R. and Vartanian, T. (2007) Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals. J Neurosci, 27: 13033-13041. (Pubitemid 350159595)
4. Caspi, A. and Moffitt, T. E. (2006) Gene-environment interactions in psychiatry: Joining forces with neuroscience. Nat Rev Neurosci, 7: 583-590. (Pubitemid 43995433)
5. Chubb, J. E., Bradshaw, N. J., Soares, D. C., Porteous, D. J. and Millar, J. K. (2008) The DISC locus in psychiatric illness. Mol Psychiatry, 13: 36-64.
6. Clancy, B., Darlington, R. B. and Finlay, B. L. (2001) Translating developmental time across mammalian species. Neuroscience, 105: 7-17. (Pubitemid 32722089)
7. Craddock, N., Owen, M. J. and O'Donovan, M. C. (2006) The catechol-O-methyl transferase (COMT) gene as a candidate for psychiatric phenotypes: Evidence and lessons. Mol Psychiatry, 11: 446-458.
8. De Oliveira, I. R. and Juruena, M. F. (2006) Treatment of psychosis: 30 years of progress. J Clin Pharm Ther, 31: 523-534. (Pubitemid 44813765)
9. Garbett, K., Ebert, P. J., Mitchell, A., Lintas, C., Manzi, B., Mirnics, K. and Persico, A. M. (2008) Immune transcriptome alterations in the temporal cortex of subjects with autism. Neurobiol Dis, 30: 303-311.
10. Glantz, L. A. and Lewis, D. A. (2000) Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry, 57: 65-73. (Pubitemid 30035660)
11. Hikida, T., Jaaro-Peled, H., Seshadri, S., Oishi, K., Hookway, C., Kong, S., Wu, D., Xue, R., Andradé, M., Tankou, S., Mori, S., Gallagher, M., Ishizuka, K., Pletnikov, M., Kida, S. and Sawa, A. (2007) Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans. Proc Natl Acad Sci USA, 104: 14501-14506. (Pubitemid 350003290)
12. Ibi, D., Nagai, T., Kitahara, Y., Mizoguchi, H., Koike, H., Shiraki, A., Takuma, K., Kamei, H., Noda, Y., Nitta, A., Nabeshima, T., Yoneda, Y. and Yamada, K. (2009) Neonatal polyI:C treatment in mice results in schizophrenia-like behavioral and neurochemical abnormalities in adulthood. Neurosci Res, 64: 297-305.
13. Ibi, D., Nagai, T., Koike, H., Kitahara, Y., Mizoguchi, H., Niwa, M., Jaaro-Peled, H., Nitta, A., Yoneda, Y., Nabeshima, T., Sawa, A. and Yamada, K. (2010) Combined effect of neonatal immune activation and mutant DISC1 on phenotypic changes in adulthood. Behav Brain Res, 206: 32-37.
14. Ikeda, M., Hikita, T., Taya, S., Uraguchi-Asaki, J., Toyo-oka, K., Wynshaw-Boris, A., Ujike, H., Inada, T., Takao, K., Miyakawa, T., Ozaki, N., Kaibuchi, K. and Iwata, N. (2008) Identification of YWHAE, a gene encoding 14-3-3epsilon, as a possible susceptibility gene for schizophrenia. Hum Mol Genet, 17: 3212-3222.
15. Ishizuka, K., Paek, Matt., Kamiya, A. and Sawa, A. (2006) A review of Disrupted-in-Schizophrenia-1 (disc1) : Neurodevelopment, cognition, and mental conditions. Biol Psychiatry, 59: 1189-1197.
16. Iwamoto, K., Kakiuchi, C., Bundo, M., Ikeda, K. and Kato, T. (2004) Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol Psychiatry, 9: 406-416. (Pubitemid 38534701)
17. Jaaro-Peled, H., Ayhan, Y., Pletnikov, M.V. and Sawa, A. (2010) Review of pathological hallmarks of schizophrenia: Comparison of genetic models with patients and nongenetic models. Schizophr Bull, 36: 301-313.
18. Jaffee, S. R. and Price, T. S. (2007) Gene-environment correlations: A review of the evidence and implications for prevention of mental illness. Mol Psychiatry, 12: 432-442. (Pubitemid 46652458)
19. James, R., Adams, R. R., Christie, S., Buchanan, S. R., Porteous, D. J. and Millar, J. K. (2004) Disrupted in Schizophrenia 1 (DISC1) is a multicompartmentalized protein that predominantly localizes to mitochondria. Mol Cell Neurosci, 26: 112-122. (Pubitemid 38581027)
20. Kirkpatrick, B., Xu, L., Cascella, N., Ozeki, Y., Sawa, A. and Roberts, R. C. (2006) DISC1 immunoreactivity at the light and ultrastructural level in the human neocortex. J Comp Neurol, 497: 436-450. (Pubitemid 43865795)
21. Lewis, D. A., Cruz, D. A., Melchitzky, D. S. and Pierri, J. N. (2001) Lamina-specific deficits in parvalbumin-immunoreactive varicosities in the prefrontal cortex of subjects with schizophrenia: Evidence for fewer projections from the thalamus. Am J Psychiatry, 158: 1411-1422. (Pubitemid 32847239)
22. Lewis, D. A., Hashimoto, T. and Volk, D. W. (2005) Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci, 6: 312-324. (Pubitemid 40469985)
23. Li, W., Zhang, Q., Oiso, N., Novak, E. K., Gautam, R., O'Brien, E. P., Tinsley, C. L., Blake, D. J., Spritz, R.A., Copeland, N. G., Jenkins, N. A., Amato, D., Roe, B. A., Starcevic, M., Dell'Angelica, E. C., Elliott, R. W., Mishra, V., Kingsmore, S. F., Paylor, R. E. and Swank, R. T. (2003) Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1). Nat Genet, 35: 84-89. (Pubitemid 37048600)
24. Li, W., Zhou, Y., Jentsch, J. D., Brown, R. A., Tian, X., Ehninger, D., Hennah, W., Peltonen, L., Lönnqvist, J., Huttunen, M. O., Kaprio, J., Trachtenberg, J. T., Silva, A. J. and Cannon, T. D. (2008) Specific developmental disruption of disrupted-in-schizophrenia-1 function results in schizophrenia-related phenotypes in mice. Proc Natl Acad Sci USA, 104: 18280-18285. (Pubitemid 350210858)
25. Lisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S. and Grace, A. A. (2008) Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci, 31: 234-242.
26. Meyer, U., Feldon, J., Schedlowski, M. and Yee, B. K. (2005) Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci Biobehav Rev, 29: 913-947. (Pubitemid 41097394)
27. Meyer, U., Nyffeler, M., Engler, A., Urwyler, A., Schedlowski, M., Knuesel, I., Yee, B. K. and Feldon, J. (2006) The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci, 26: 4752-4762. (Pubitemid 44315314)
28. Meyer, U., Nyffeler, M., Schwendener, S., Knuesel I., Yee, B. K. and Feldon, J. (2008) Relative prenatal and postnatal maternal contributions to schizophrenia-related neurochemical dysfunction after in utero immune challenge. Neuropsychopharmacology, 33: 441-456. (Pubitemid 350243354)
29. Millar, J. K., Wilson-Annan, J. C., Anderson, S., Christie, S., Taylor, M. S., Semple, C. A., Devon, R. S., St Clair, D. M., Muir, W. J., Blackwood, D. H. and Porteous, D. J. (2000) Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet, 9: 1415-1423. (Pubitemid 30312490)
30. Millar, J. K., James, R., Brandon, N. J. and Thomson, P. A. (2004) DISC1 and DISC2: Discovering and dissecting molecular mechanisms underlying psychiatric illness. Ann Med, 36: 367-378. (Pubitemid 39233104)
31. Miyoshi, K., Asanuma, M., Miyazaki, I., Diaz-Corrales, F.J., Katayama, T., Tohyama, M. and Ogawa, N. (2004) DISC1 localizes to the centrosome by binding to kendrin. Biochem Biophys Res Commun, 317: 1195-1199. (Pubitemid 38496437)
32. Mouri, A., Noda, Y., Enomoto, T. and Nabeshima, T. (2007) Phencyclidine animal models of schizophrenia: Approaches from abnormality of glutamatergic neurotransmission and neurodevelopment. Neurochem Int, 51: 173-184. (Pubitemid 47176714)
33. Nagai, T., Kitahara, Y., Shiraki, A., Hikita, T., Taya, S., Kaibuchi, K. and Yamada, K. (2010) Dysfunction of dopamine release in the prefrontal cortex of dysbindin deficient sandy mice: An in vivo microdialysis study. Neurosci Lett, 470: 134-138.
34. Nagai, T., Ibi, D. and Yamada, K. (2011) Animal model for schizophrenia that reflects gene-environment interactions. Biol Pharm Bull, 34: 1364-1368.
35. Nawa, H. and Takei, N. (2006) Recent progress in animal modeling of immune inflammatory processes in schizophrenia: Implication of specific cytokines. Neurosci Res, 56: 2-13. (Pubitemid 44376487)
36. Niwa, M., Kamiya, A., Murai, R., Kubo, K., Gruber, A.J., Tomita, K., Lu, L., Tomisato, S., Jaaro-Peled, H., Seshadri, S., Hiyama, H., Huang, B., Kohda, K., Noda, Y., O'Donnell, P., Nakajima, K., Sawa, A. and Nabeshima, T. (2010) Knockdown of DISC1 by in utero gene transfer disturbs postnatal dopaminergic maturation in the frontal cortex and leads to adult behavioral deficits. Neuron, 65: 480-489.
37. Nuechterlein, K. H., Barch, D. M., Gold, J. M., Goldberg, T. E., Green, M. F. and Heaton, R. K. (2004) Identification of separable cognitive factors in schizophrenia. Schizophr Res, 72: 29-39. (Pubitemid 39452903)
38. Ozawa, K., Hashimoto, K., Kishimoto, T., Shimizu, E., Ishikura, H. and Iyo, M. (2006) Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: A neurodevelopmental animal model of schizophrenia. Biol Psychiatry, 59: 546-554. (Pubitemid 43320543)
39. Ozeki, Y., Tomoda, T., Kleiderlein, J., Kamiya, A., Bord, L., Fujii, K., Okawa, M., Yamada, N, Hatten, M.E., Snyder, S.H., Ross, C.A. and Sawa, A. (2003) Disrupted-in-Schizophrenia-1 (DISC-1) : Mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth. Proc Natl Acad Sci USA, 100: 289-294. (Pubitemid 36078067)
40. Patterson, P. H. (2007) Maternal effects on schizophrenia risk. Science, 318: 576-577.
41. Pearlson, G. D. (2000) Neurobiology of schizophrenia. Ann Neurol, 48: 556-566.
42. Purcell, S. M., Wray, N. R., Stone, J. L., Visscher, P. M., O'Donovan, M. C., Sullivan, P. F. and Sklar, P. (2009) Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature, 460: 748-752.
43. Roberts, R. C. (2007) Schizophrenia in translation: Disrupted in schizophrenia (DISC1) : Integrating clinical and basic findings. Schizophr Bull, 33: 11-15.
44. Ross, C. A., Margolis, R. L., Reading, S. A. J., Pletnikov, M. and Coyle, J. T. (2006) Neurobiology of schizophrenia. Neuron, 52: 139-153. (Pubitemid 44466356)
45. Rössler, W., Salize, H.J., van Os, J. and Riecher-Rössler, A. (2005) Size of burden of schizophrenia and psychotic disorders. Eur Neuropsychopharmacol, 15: 399-409.
46. Sawa, A. and Snyder, S.H. (2002) Schizophrenia: Diverse approaches to a complex disease. Science, 296: 692-695. (Pubitemid 34441987)
47. Sawa, A., Pletnikov, M. V. and Kamiya, A. (2004) Neuron-glia interactions clarify genetic-environmental links in mental illness. Trends Neurosci, 27: 294-297. (Pubitemid 38692408)
48. Shenton, M. E., Dickey, C. C., Frumin, M. and McCarley, R. W. (2001) A review of MRI findings in schizophrenia. Schizophr Res, 15: 1-52. (Pubitemid 32451739)
49. Shi, L. S., Fatemi, H., Sidwell, R. W. and Patterson, P. H. (2003) Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci, 23: 297-302. (Pubitemid 36050430)
50. Shi, J., Levinson, D. F., Duan, J., Sanders, A. R., Zheng, Y., Pe'er, I., Dudbridge, F., Holmans, P. A., Whittemore, A. S., Mowry, B. J., Olincy, A., Amin, F., Cloninger, C. R., Silverman, J. M., Buccola, N. G., Byerley, W. F., Black, D. W., Crowe, R. R., Oksenberg, J. R., Mirel, D. B., Kendler, K. S., Freedman, R. and Gejman, P. V. (2009) Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature, 460: 753-757.
51. Smith, S. E. P., Li, J., Garbett, K., Mirnics, K. and Patterson, P. H. (2007) Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci, 27: 10695-10702. (Pubitemid 47535869)
52. Steen, R. G., Mull, C., McClure, R., Hamer, R. M. and Lieberman, J. A. (2006) Brain volume in first-episode schizophrenia: Systematic review and meta-analysis of magnetic resonance imaging studies. Br J Psychiatry, 188: 510-518. (Pubitemid 43844097)
53. Stefansson, H., Sigurdsson, E., Steinthorsdottir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., Brynjolfsson, J., Gunnarsdottir, S., Ivarsson, O., Chou, T. T., Hjaltason, O., Birgisdottir, B., Jonsson, H., Gudnadottir, V. G., Gudmundsdottir, E., Bjornsson, A., Ingvarsson, B., Ingason, A., Sigfusson, S., Hardardottir, H., Harvey, R.P., Lai, D., Zhou, M., Brunner, D., Mutel, V., Gonzalo, A., Lemke, G., Sainz, J., Johannesson, G., Andresson, T., Gudbjartsson, D., Manolescu, A., Frigge, M. L., Gurney, M. E., Kong, A., Gulcher, J. R., Petursson, H. and Stefansson, K. (2002) Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet, 71: 877-892. (Pubitemid 135750519)
54. Stefansson, H., Ophoff, R. A., Steinberg, S., Andreassen, O. A., Cichon, S., Rujescu, D., Werge, T., Pietiläinen, O. P., Mors, O., Mortensen, P. B., Sigurdsson, E., Gustafsson, O., Nyegaard, M., Tuulio-Henriksson, A., Ingason, A., Hansen, T., Suvisaari, J., Lonnqvist, J., Paunio, T., Børglum, A.D., Hartmann, A., Fink-Jensen, A., Nordentoft, M., Hougaard, D., Norgaard-Pedersen, B., Bottcher, Y., Olesen, J., Breuer, R., Moller, H.J., Giegling, I., Rasmussen, H. B., Timm, S., Mattheisen, M., Bitter, I., Rethelyi, J. M., Magnusdottir, B.B., Sigmundsson, T., Olason, P., Masson, G., Gulcher, J. R., Haraldsson, M., Fossdal, R., Thorgeirsson, T. E., Thorsteinsdottir, U., Ruggeri, M., Tosato, S., Franke, B., Strengman, E., Kiemeney, L. A., Genetic Risk and Outcome in Psychosis (GROUP), Melle, I., Djurovic, S., Abramova, L., Kaleda, V., Sanjuan, J., de Frutos, R., Bramon, E., Vassos, E., Fraser, G., Ettinger, U., Picchioni, M., Walker, N., Toulopoulou, T., Need, A. C., Ge, D., Yoon, J. L., Shianna, K. V., Freimer, N. B., Cantor, R. M., Murray, R., Kong, A., Golimbet, V., Carracedo, A., Arango, C., Costas, J., Jonsson, E. G., Terenius, L., Agartz, I., Petursson, H., Nothen, M.M., Rietschel, M., Matthews, P. M., Muglia, P., Peltonen, L., St Clair, D., Goldstein, D. B., Stefansson, K. and Collier, D. A. (2009) Common variants conferring risk of schizophrenia. Nature, 460: 744-747.
55. Straub, R. E., Jiang, Y., MacLean, C. J., Ma, Y., Webb, B. T., Myakishev, M. V., Harris-Kerr, C., Wormley, B., Sadek, H., Kadambi, B., Cesare, A. J., Gibberman, A., Wang, X., O'Neill, F. A., Walsh, D. and Kendler, K. S. (2002) Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet, 71: 337-348. (Pubitemid 34800250)
56. Sullivan, P. F., Kendler, K. S. and Neale, M. C. (2003) Schizophrenia as a complex trait: Evidence from a meta-analysis of twin studies. Arch Gen Psychiatry, 60: 1187-1192. (Pubitemid 37494071)
57. Tan, H. Y., Callicott, J. H. and Weinberger, D. R. (2008) Intermediate phenotypes in schizophrenia genetics redux: Is it a no brainer? Mol Psychiatry, 13: 233-238. (Pubitemid 351272661)
58. Tordjman, S., Drapier, D., Bonnot, O., Graignic, R., Fortes, S., Cohen, D., Millet, B., Laurent, C. and Roubertoux, P. L. (2007) Animal models relevant to schizophrenia and autism: Validity and limitations. Behav Genet, 37: 61-78. (Pubitemid 46144053)
59. Toyo-oka, K., Shionoya, A., Gambello, M. J., Cardoso, C., Leventer, R., Ward, H. L., Ayala, R., Tsai, L. H., Dobyns, W., Ledbetter, D., Hirotsune, S. and Wynshaw-Boris, A. (2003) 14-3-3ε is important for neuronal migration by binding to NUDEL: A molecular explanation for Miller-Dieker syndrome. Nat Genet, 34: 274-285. (Pubitemid 36792859)
60. Tsuang, M. (2000) Schizophrenia: Genes and environment. Biol Psychiatry, 47: 210-220.
61. Flavell. R. A. (2004) Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med, 10: 1366-1373. (Pubitemid 40022719)
62. Zuckerman, L., Rehavi, M., Nachman, R. and Weiner, I. (2003) Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: A novel neurodevelopmental model of schizophrenia. Neuropsychopharmacology, 28: 1778-1789. (Pubitemid 41070843)
63. Zuckerman, L. and Weiner, I. (2005) Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring. J Psychiatry Res, 39: 311-323. (Pubitemid 40255916)